Evidence map›Paper›PMID 12490960›Full record

ReviewNature

Inflammation in atherosclerosis.

Peter Libby

4 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00988364. Cited by 2,829 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,829citing papers in PubMed, 6 pooled it
70.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00988364 phase4completed

Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 in Patients With Metabolic Syndrome

Ran2007Enrolled30Registered outcomes2Posted comparisons0ConditionsMetabolic SyndromeArmsEzetimibe, Placebo, simvastatin, Vytorin
Open the trial in the graph
NCT02114697 phase4terminated

Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging

Ran2014Enrolled9Registered outcomes1Posted comparisons0ConditionsAtherosclerosisArmsLifestyle Modification, Statin therapy
Open the trial in the graph
NCT03467230 completednot on this map

Performance Assessment of the PMD-200 in Subjects Requiring Surgery Under General Anesthesia

TypeobservationalSponsorUniversity of VermontRan2018 to 2018Enrolled61ConditionsPain, Opioid Use, Intraoperative ComplicationsArmsNoL Index
NCT07149883 not yet recruitingnot on this map

Evaluation of Mean Platelet Volume and Systemic Inflammatory Response Index (SIRI) in Patients of Acute Coronary Syndrome

TypeobservationalSponsorAssiut UniversityRan2025 to 2026Enrolled300ConditionsCoronary Artery DiseaseArmsComplete blood count, ECHO
3 · Its place in the literature

Who cites it

2,829 citing papers in PubMed, 6 syntheses or guidelines pooled it, 8,076 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Visceral Adiposity Index in Coronary Artery Ectasia.The Eurasian journal of medicine · 2026
    Article
  20. Article

2,769 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Peter LibbyDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. plibby@rics.bwh.harvard.edu
Brigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abundant data link hypercholesterolaemia to atherogenesis. However, only recently have we appreciated that inflammatory mechanisms couple dyslipidaemia to atheroma formation. Leukocyte recruitment and expression of pro-inflammatory cytokines characterize early atherogenesis, and malfunction of inflammatory mediators mutes atheroma formation in mice. Moreover, inflammatory pathways promote thrombosis, a late and dreaded complication of atherosclerosis responsible for myocardial infarctions and most strokes. The new appreciation of the role of inflammation in atherosclerosis provides a mechanistic framework for understanding the clinical benefits of lipid-lowering therapies. Identifying the triggers for inflammation and unravelling the details of inflammatory pathways may eventually furnish new therapeutic targets.

Indexed as

AnimalsArteriosclerosisChemotaxis, LeukocyteDisease SusceptibilityHumansInflammationLeukocytesRiskTunica Intima

Identifiers

PMID12490960
OpenAlexW2066963386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.